Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy.
Oral squamous cell carcinoma (OSCC) patients diagnosed in late stages have limited chemotherapeutic options underscoring the great need for development of new anticancer agents for more effective disease management. We aimed to investigate the anticancer potential of Apaziquone, [EOquin, USAN, E09,...
Main Authors: | Gunjan Srivastava, Raj Thani Somasundaram, Paul G Walfish, Ranju Ralhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4514673?pdf=render |
Similar Items
-
EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
by: MacMillan Christina, et al.
Published: (2010-06-01) -
Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
by: Guodong Fu, et al.
Published: (2017-04-01) -
Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft
by: Surang Leelawat, et al.
Published: (2022-01-01) -
Sandensolide Induces Oxidative Stress-Mediated Apoptosis in Oral Cancer Cells and in Zebrafish Xenograft Model
by: Chung-I Yu, et al.
Published: (2018-10-01) -
Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer
by: Hsing-Ying Lee, et al.
Published: (2020-04-01)